Monday, July 4, 2016

Advaxis: Manufacturing, safety and efficiency key to developing cancer drugs

… most important other element for cancer immunotherapies and for product candidates … candidate, human papillomavirus (HPV)-associated cancer drug Axalimogene Filolisbac.
O'Connor … bacteria to express tumour-associated antigens, such as the prostate specific antigen, the …

No comments:

Post a Comment